Raymond James Maintains Outperform on Insulet, Lowers Price Target to $228
Benzinga · 6d ago
Raymond James analyst Jayson Bedford maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $299 to $228.